Glucose homeostasis is impaired in mice deficient for the neuropeptide 26RFa (QRFP)
Authors:
- Mouna El MehdiMMMouna El Mehdi
- Saloua TakhlidjtSTSaloua Takhlidjt
- Fayrouz KhiarFKFayrouz Khiar
- Gaëtan PrévostGPGaëtan Prévost
- Jean-Luc Do RegoJRJean-Luc Do Rego
- Jean-Claude Do RegoJRJean-Claude Do Rego
- Alexandre BénaniABAlexandre Bénani
- Emmanuelle NedelecENEmmanuelle Nedelec
- David GodefroyDGDavid Godefroy
- Arnaud AraboAAArnaud Arabo
- Benjamin LefrancBLBenjamin Lefranc
- Jérôme LeprinceJLJérôme Leprince
Preprint
Abstract
Introduction: 26RFa (QRFP) is a biologically active peptide that has been found to control feeding behaviour by stimulating food intake, and to regulate glucose homeostasis by acting as an incretin. The aim of the present study was thus to investigate the impact of 26RFa gene knockout on the regulation of energy and glucose metabolism. Research design and methods: 26RFa mutant mice were generated by homologous recombination, in which the entire coding region of prepro-26RFa was replaced by the iCre sequence. Energy and glucose metabolism was evaluated through measurement of complementary parameters. Morphological and physiological alterations of the pancreatic islets were also investigated. Results: Our data do not reveal significant alteration of energy metabolism in the 26RFa-deficient mice except the occurrence of an increased basal metabolic rate. By contrast, 26RFa mutant mice exhibit an altered glycemic phenotype with an increased hyperglycemia after a glucose challenge associated with an impaired insulin production, and an elevated hepatic glucose production. 2D and 3D immunohistochemical experiments indicate that the insulin content of pancreatic β cells is much lower in the 26RFa -/- mice as compared to the wild-type littermates. Conclusion: Disruption of the 26RFa gene induces substantial alteration in the regulation of glucose homeostasis with, in particular, a deficit in insulin production by the pancreatic islets. These findings further support the notion that 26RFa is an important regulator of glucose homeostasis. Significance of this study: What is already known about this subject?: 26RFa is a biologically active peptide produced in abundance in the gut and the pancreas. 26RFa has been found to regulate glucose homeostasis by acting as an incretin and by increasing insulin sensitivity. What are the new findings?: Disruption of the 26RFa gene induces substantial alteration in the regulation of glucose homeostasis with, in particular, a deficit in insulin production by the pancreatic islets, assessing therefore the notion that 26RFa is an important regulator of glucose homeostasis. How might these results change the focus of research or clinical practice?: Identification of a novel actor in the regulation of glucose homeostasis is crucial to better understand the general control of glucose metabolism in physiological and pathophysiological conditions, and opens new fields of investigation to develop innovative drugs to treat diabetes mellitus.Keywords
All Related Versions
- Published version: BMJ Open Diabetes Research & Care, 8 (1), e000942.
This publication has 31 references indexed in Scilit:
- Hypothalamic Neurones Governing Glucose HomeostasisJournal of Neuroendocrinology, 2015
- Leptin Engages a Hypothalamic Neurocircuitry to Permit Survival in the Absence of InsulinCell Metabolism, 2013
- The RFamide neuropeptide 26RFa and its role in the control of neuroendocrine functionsFrontiers in Neuroendocrinology, 2011
- Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humansAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- CRFR1 is expressed on pancreatic β cells, promotes β cell proliferation, and potentiates insulin secretion in a glucose-dependent mannerProceedings of the National Academy of Sciences, 2009
- Central insulin action in energy and glucose homeostasisJournal of Clinical Investigation, 2006
- Identification of 26RFa, a hypothalamic neuropeptide of the RFamide peptide family with orexigenic activityProceedings of the National Academy of Sciences, 2003
- A New Peptidic Ligand and Its Receptor Regulating Adrenal Function in RatsJournal of Biological Chemistry, 2003
- Identification and Characterization of a Novel RF-amide Peptide Ligand for Orphan G-protein-coupled Receptor SP9155Journal of Biological Chemistry, 2003
- Glucose Regulates the Release of Orexin-A From the Endocrine PancreasDiabetes, 2003